RxDoctor Payments DataLook up a doctor →

Robert Vangossen, MD

Family Medicine · Lake Charles, LANPI 1437546595

Payments from drug & device makers

$14,213in general payments, 2019–2025

Across 849 payments — averaging $16.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AbbVie$2K
  • Amgen$1K
  • AstraZeneca$1K
  • Lilly USA, LLC$1K
  • GSK$968
  • plus $6K from 35 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk113$1,675
AbbVie(2 entities)98$1,580
Amgen77$1,368
AstraZeneca57$1,214
Lilly USA, LLC80$1,044
GSK52$968
Pfizer54$873
Boehringer Ingelheim33$673
Astellas Pharma US Inc29$516
Merck23$382
Novartis22$353
Bayer19$336
Amarin Pharma, Inc.14$315
Sumitomo Pharma America, Inc.15$296
Takeda Pharmaceuticals U.S.A., Inc.18$289
Esperion Therapeutics, Inc.19$264
Abbott12$224
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC17$223
Axsome Therapeutics, Inc.9$179
Exact Sciences9$164
Kowa Pharmaceuticals America, Inc.9$163
Teva Pharmaceuticals USA, Inc.9$137
Dexcom, Inc.7$130
Sanofi-aventis U.S. LLC8$124
Sunovion Pharmaceuticals Inc.9$99
Idorsia Pharmaceuticals US Inc6$89
Avanir Pharmaceuticals, Inc.5$78
Biohaven Pharmaceutical Holding Company Ltd.4$78
Johnson & Johnson4$64
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$49
Vanda Pharmaceuticals Inc.2$44
Currax Pharmaceuticals LLC3$40
Eisai Inc.2$27
Arbor Pharmaceuticals, Inc.2$27
Ironshore Pharmaceuticals Inc.1$20
Neurocrine Biosciences, Inc.1$20
Otsuka America Pharmaceutical, Inc.1$20
Noven Therapeutics, LLC1$19
Lundbeck LLC1$18
Vivus LLC1$18
Vyera Pharmaceuticals, LLC1$14

How this compares

$14,213 in reported general payments places this provider in the 95th percentile of 1,469 family medicine providers in Louisiana.

See all family medicine providers in Louisiana →

Medicare billing

Part B allowed, 2024
$66,240
Medicare patients
203
Services billed
1,133

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Lake Charles

See the full list for Louisiana →

Where these figures come from

Is this you, or does something look wrong? →